Annexon, Inc. (ANNX)
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated neurodegeneration. Its product candidates include ANX005, a monoclonal antibody, which is in Phase II/III clinical trials to treat patients with guillain- barré syndrome; Phase II trial in patients with warm autoimmune hemolytic anemia; and Phase II clinical trial for Huntington's disease and amyotrophic lateral sclerosis. The company is also developing ANX009 that is in Phase Ib trial in patients with lupus nephritis; and ANX007, which is in Phase II clinical trials to treat patients with geographic atrophy. In addition, it develops ANX105, an investigational monoclonal antibody targeting neurodegenerative indications; and ANX1502, an investigational oral small molecule for the treatment of certain autoimmune indications. The company was incorporated in 2011 and is headquartered in Brisbane, California.
$742.22M
Mr. Douglas Love J.D., Esq.
83.00
Brisbane, CA
Jul 24, 2020
-5.81
$-1.21
9.17
21.81
-2,366.61%
-7.90
-0.08
2.52
151.77
21.81
-28.36%
-44.68%
Similar stocks (14)
Blueprint Medicines Corporation
BPMC
Structure Therapeutics Inc.
GPCR
Arcus Biosciences, Inc.
RCUS
Relay Therapeutics, Inc.
RLAY
Day One Biopharmaceuticals, Inc.
DAWN
Cullinan Oncology, Inc.
CGEM
Inozyme Pharma, Inc.
INZY
Amylyx Pharmaceuticals, Inc.
AMLX
Acumen Pharmaceuticals, Inc.
ABOS
X4 Pharmaceuticals, Inc.
XFOR
Immix Biopharma, Inc.
IMMX
IN8bio, Inc.
INAB
CNS Pharmaceuticals, Inc.
CNSP
Hepion Pharmaceuticals, Inc.
HEPA
ETF Exposure (29)
iShares Micro-Cap ETF
IWC
0.13169%
Vanguard U.S. Momentum Factor ETF
VFMO
0.11%
Vanguard Russell 2000 Value Index Fund
VTWV
0.04%
iShares Russell 2000 Value ETF
IWN
0.039%
Vanguard Russell 2000 Index Fund
VTWO
0.02%
iShares Russell 2000 ETF
IWM
0.01919%
Dimensional U.S. Small Cap ETF
DFAS
0.01011567%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0.01%
Vanguard Extended Market Index Fund
VXF
0.01%
ProShares Ultra Russell2000
UWM
0.007261114820136342%
Dimensional U.S. Core Equity 2 ETF
DFAC
0.00470064%
ALPS Medical Breakthroughs ETF
SBIO
0.0037%
ProShares UltraPro Russell2000
URTY
0.0035788623538880833%
ProShares Hedge Replication ETF
HDG
0.003029870886355176%
Dimensional US Sustainability Core 1 ETF
DFSU
0.00116616%
iShares Core S&P Total U.S. Stock Market ETF
ITOT
0.00116%
Dimensional US Core Equity Market ETF
DFAU
0.0011491000000000001%
iShares Russell 3000 ETF
IWV
9.5e-4%
Dimensional U.S. Equity ETF
DFUS
7.9999e-4%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
GSSC
0%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Similar stocks (14)
Blueprint Medicines Corporation
BPMC
Structure Therapeutics Inc.
GPCR
Arcus Biosciences, Inc.
RCUS
Relay Therapeutics, Inc.
RLAY
Day One Biopharmaceuticals, Inc.
DAWN
Cullinan Oncology, Inc.
CGEM
Inozyme Pharma, Inc.
INZY
Amylyx Pharmaceuticals, Inc.
AMLX
Acumen Pharmaceuticals, Inc.
ABOS
X4 Pharmaceuticals, Inc.
XFOR
Immix Biopharma, Inc.
IMMX
IN8bio, Inc.
INAB
CNS Pharmaceuticals, Inc.
CNSP
Hepion Pharmaceuticals, Inc.
HEPA
ETF Exposure (29)
iShares Micro-Cap ETF
IWC
0.13169%
Vanguard U.S. Momentum Factor ETF
VFMO
0.11%
Vanguard Russell 2000 Value Index Fund
VTWV
0.04%
iShares Russell 2000 Value ETF
IWN
0.039%
Vanguard Russell 2000 Index Fund
VTWO
0.02%
iShares Russell 2000 ETF
IWM
0.01919%
Dimensional U.S. Small Cap ETF
DFAS
0.01011567%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0.01%
Vanguard Extended Market Index Fund
VXF
0.01%
ProShares Ultra Russell2000
UWM
0.007261114820136342%
Dimensional U.S. Core Equity 2 ETF
DFAC
0.00470064%
ALPS Medical Breakthroughs ETF
SBIO
0.0037%
ProShares UltraPro Russell2000
URTY
0.0035788623538880833%
ProShares Hedge Replication ETF
HDG
0.003029870886355176%
Dimensional US Sustainability Core 1 ETF
DFSU
0.00116616%
iShares Core S&P Total U.S. Stock Market ETF
ITOT
0.00116%
Dimensional US Core Equity Market ETF
DFAU
0.0011491000000000001%
iShares Russell 3000 ETF
IWV
9.5e-4%
Dimensional U.S. Equity ETF
DFUS
7.9999e-4%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
GSSC
0%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%